LEQSELVI
Live / Registered — Registered (as of 04 Nov 2025)
What this means for you
Registered since 04 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90505049
- Registration number
- 8014011
- Mark type
- Stylized text
- Filed
- 02 Feb 2021
- Published for opposition
- 26 Oct 2021
- Registered
- 04 Nov 2025
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases
Owner
- SUN PHARMACEUTICAL INDUSTRIES, INC., PRINCETON, NJ, US
- SUN PHARMACEUTICAL INDUSTRIES, INC., PRINCETON, NJ, US
- Concert Pharmaceuticals, Inc., Lexington, MA, US
- Concert Pharmaceuticals, Inc., Lexington, MA, US
Prosecution history
- 08 Jan 2026 — TEAS SECTION 7 REQUEST RECEIVED
- 04 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Apr 2025 — USE AMENDMENT FILED
- 05 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 18 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Oct 2024 — SOU EXTENSION 5 GRANTED
- 18 Oct 2024 — SOU EXTENSION 5 FILED
- 18 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2024 — SOU EXTENSION 4 GRANTED